Clinical trials report average reductions of over 20% of body weight over 72 weeks
Of the participants with both EHR and survey data, 125 self-reported using semaglutide, of whom 97.6% had a corroborating EHR record
GHK-Cu is not a medicine , it is registered as a cosmetic ingredient (INCI: Copper Tripeptide-1) in the EU and USA
Body recomposition as a research variable Body recomposition is treated in research settings as a distinct variable from fat loss alone, since it requires measuring two outcomes adipose reduction and lean mass retention rather than tracking either in isolation
In the few studies that interrogate cerebral effects, APAP intoxication is associated with spatial and non-spatial memory deficits alongside elevated levels of oxidative stress and gliosis 26,27,28,29,30,31,32